Is Kisspeptin-10 safe?
Supervised infusions only; no self-injection data
BSome human evidenceNot approvedas of 2026-10-26
In the Imperial College studies, men tolerated kisspeptin infusions well. There were no serious adverse events at the trial doses. In animals, constant high exposure can desensitise the receptor. Then it suppresses the axis instead of driving it. That is a caution for repeated use. All human data come from supervised infusions into a vein of pharmaceutical-grade peptide. No one knows what happens when people inject research-chemical kisspeptin-10 again and again. 546
Read the full Kisspeptin-10 page
More on Kisspeptin-10
Citations
- World Anti-Doping Agency: prohibited list wada-ama.org
- Comninos 2017, Journal of Clinical Investigation: kisspeptin modulates sexual and emotional brain processing in humans doi.org
- Comninos 2018, JCI Insight: modulations of human resting brain connectivity by kisspeptin doi.org
- Mills 2023, JAMA Network Open: kisspeptin in men with hypoactive sexual desire disorder, randomised crossover trial doi.org
- Patel 2023, Endocrine Reviews: kisspeptin and neurokinin B, review doi.org
- George 2013, Clinical Endocrinology: kisspeptin-10 stimulates testosterone and LH in men with type 2 diabetes pubmed.ncbi.nlm.nih.gov
Reference information only, not medical advice. Drawn from the Kisspeptin-10 article, fact-checked against the cited sources. No dosing anywhere on this site.